跳至主要内容
临床试验/NCT07546331
NCT07546331招募中不适用

Investigation Into the Utility of Novel Body Composition Measurements in Association With Outcomes of Breast Reconstruction

University of California, San Francisco1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2026年2月18日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
40
试验地点
1
主要终点
Proportion of Body Composition Measurement Collection

研究概览

简要总结

This study compares measurements of body composition to outcomes of breast reconstruction.

详细描述

PRIMARY OBJECTIVES:

1. Determine feasibility of collecting measurements of body composition.

SECONDARY OBJECTIVES:

  1. Define the differences in body composition between participants undergoing breast reconstruction who develop complications and those who do not.
  2. To determine the implications of different measures of body composition on outcomes of breast reconstruction.
  3. Compare utility of body composition measurements versus other anthropometric assessments on assessing risk of complications following breast surgery.

OUTLINE: This is a observational study. Participants are assigned to 1 of 2 cohorts and will be follow-up for up to 2 years.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients must have histologically confirmed breast malignancy or increased risk of developing a breast malignancy.
  • Age ≥ 18 years.
  • Scheduled to undergo mastectomy with immediate breast reconstruction using a permanent implant, tissue expander, or autologous tissue (e.g. Deep Inferior Epigastric Perforator (DIEP) flap, muscle-sparing Transverse Rectus Abdominis Myocutaneous (msTRAM) flap, Profunda Artery Perforator (PAP) flap).
  • Ability to understand a written informed consent document, and the willingness to sign it.

排除标准

  • Any significant medical condition or laboratory abnormalities, which places the subject at unacceptable risk if he/she were to participate in the study.
  • Pregnant or breastfeeding.
  • Patients assigned male at birth.
  • Non-cisgender women.
  • Patients with implanted electronic medical devices (e.g. pacemaker, defibrillator).
  • Patients with prosthetic limbs.

研究组 & 干预措施

Cohort A: Implant-based Reconstruction

Patients undergo standard of care implant-based breast reconstruction and body composition measurement on study.

干预措施: Measurement of Body Composition (Procedure)

Cohort A: Implant-based Reconstruction

Patients undergo standard of care implant-based breast reconstruction and body composition measurement on study.

干预措施: Chart Review (Other)

Cohort B: Autologous Reconstruction

Patients undergo standard of care autologous breast reconstruction and body composition measurement on study.

干预措施: Measurement of Body Composition (Procedure)

Cohort B: Autologous Reconstruction

Patients undergo standard of care autologous breast reconstruction and body composition measurement on study.

干预措施: Chart Review (Other)

结局指标

主要结局

Proportion of Body Composition Measurement Collection

时间窗: up to 2 years

The proportion of enrolled participants with successfully obtained body composition measurements at both preoperative and postoperative timepoints. A success rate of ≥90% will be considered feasible. The proportion of the participants meets feasibility will be reported.

次要结局

  • Postoperative Variability of Body Composition(up to 2 years)
  • Pre- to Postoperative Changes in Body Composition and Their Association with BMI(up to 2 years)
  • Association Between Body Composition Parameters and Postoperative Complications Following Breast Reconstruction(up to 2 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验